ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation

Cancer Cell

Volumn 1, Issue 2, 2002, Pages 145-155

  Kolligs, Frank T ^a,b   Nieman, Marvin T ^a,c   Winer, Ira ^a   Hu, Gang ^a,d   Van Mater, David ^a   Feng, Ying ^a   Smith, Ian M ^a   Wu, Rong ^a   Zhai, Yali ^a   Cho, Kathleen R ^a   Fearon, Eric R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF TOLEDO   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; E1A PROTEIN; ESTROGEN RECEPTOR; HELIX LOOP HELIX PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN TRANSCRIPTION FACTOR 2; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; CATNB PROTEIN, RAT; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; ONCOPROTEIN; TCF4 PROTEIN, HUMAN; TCF4 PROTEIN, RAT; TRANSACTIVATOR PROTEIN; ZEBRAFISH PROTEIN;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA TRANSCRIPTION; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; MALIGNANT TRANSFORMATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; WILD TYPE; ANIMAL; CELL CULTURE; FEMALE; GENETICS; METABOLISM; MUTATION; NEOPLASM; OVARY TUMOR; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MUTATION; NEOPLASMS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 1642562179     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1535-6108(02)00035-1     Document Type: Article

References (64)

1. Atchley, W., and Fitch, W. (1997). A natural classification of the basic helix-loop-helix class of transcription factors. Proc. Natl. Acad. Sci. USA 94, 5172-5176.
2. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996). Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642.
3. Behrens, J., Jerchow, B.A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D., and Birchmeier, W. (1998). Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSKSβ. Science 280, 596-599.
4. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L., and Weintraub, H. (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.
5. Bienz, M., and Clevers, H. (2000). Linking colorectal cancer to Wnt signaling. Cell 103, 311-320.
6. Cadigan, K.M., and Nusse, R. (1997). Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286-3305.
7. Chen, H., Weng, Y.C., Schatteman, G.C., Sanders, L., Christy, R.J., and Christy, B.A. (1999). Expression of the dominant-negative regulator Id4 is induced during adipocyte differentiation. Biochem. Biophys. Res. Commun. 256, 614-619.
8. Corneliussen, B., Thornell, A., Hallberg, B., and Grundstrom, T. (1991). Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65, 6084-6093.
9. Couso, J.P., Bishop, S.A., and Arias, A.M. (1994). The wingless signaling pathway and the patterning of the wing margin in Drosophila. Development 120, 621-636.
10. Crawford, H.C., Fingleton, B.M., Rudolph-Owen, L.A., Goss, K.J., Rubinfeld, B., Polakis, P., and Matrisian, L.M. (1999). The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 18, 2883-2891.
11. Dahmen, R.P., Koch, A., Denkhaus, D., Tonn, J.C., Sorensen, N., Berthold, F., Behrens, J., Birchmeier, W., Wiestler, O.D., and Pietsch, T. (2001). Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res. 61, 7039-7043.
12. Dang, C.V. (1999). c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19, 1-11.
13. Gamallo, C., Palacios, J., Moreno, G., Calvo de Mora, J., Suarez, A., and Armas, A. (1999). β-catenin expression pattern in stage I and stage II ovarian carcinomas: relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome. Am. J. Pathol. 155, 527-536.
14. González-Gaitán, M., and Jäckle, H. (1995). Invagination centers within the Drosophila stomagastric nervous system anlage are positioned by Notch-mediated signaling which is spatially controlled through wingless. Development 121, 2313-2325.
15. Hart, M., Concordet, J.P., Lassot, I., Albert, I., del los Santos, R., Durand, H., Perret, C., Rubinfeld, B., Margottin, F., Benarous, R, and Polakis, P. (1999). The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr. Biol. 9, 207-210.
16. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., Da Costa, L.T., Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1998). Identification of c-Myc as a target of the APC pathway. Science 281, 1509-1512.
17. He, T.C., Chan, T.A., Vogelstein, B., and Kinzler, K.W. (1999). PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335-345.
18. Henthorn, P., Kiledjian, M., and Kadesch, T. (1990). Two distinct transcription factors that bind the immunoglobulin enhancer μE5/κE2 motif. Science 247, 467-470.
19. Iavarone, A., Garg, P., Lasorella, A., Hsu, J., and Israel, M.A. (1994). The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8, 1270-1284.
20. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. (1998). Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 17, 1371-1384.
21. Ishiguro, A., Spirin, K.S., Shiohara, M., Tobler, A., Gombart, A.F., Israel, M.A., Norton, J.D., and Koeffler, H.P. (1996). Id2 expression increases with differentiation of human myeloid cells. Blood 87, 5225-5231.
22. Jiang, J., and Struhl, G. (1998). Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 391, 493-496.
23. Johnston, L.A., and Edgar, B.A. (1998). Wingless and Notch regulate cell-cycle arrest in the developing Drosophila wing. Nature 394, 82-84.
24. Kinzler, K.W., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
25. Kitagawa, M., Hatakeyama, S., Shirane, M., Matsumoto, M., Ishida, N., Hattori, K., Nakamichi, I., Kikuchi, A., and Nakayama, K. (1999). An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin. EMBO J. 18, 2401-2410.
26. Koh, T.J., Bulitta, C.J., Fleming, J.V., Dockray, G.J., Varro, A., and Wang, T.C. (2000). Gastrin is a target of the β-catenin/Tcf-4 growth-signaling pathway in a model of intestinal polyposis. J. Clin. Invest. 106, 533-539.
27. Kolligs, F.T., Hu, G., Dang, C.V., and Fearon, E.R. (1999). Neoplastic transformation by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19, 5696-5706.
28. Kolligs, F.T., Kolligs, B., Hajra, K.M., Hu, G., Tani, M., Cho, K.R., and Fearon, E.R. (2000). γ-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev. 14, 1319-1331.
29. Korinek, V., Barker, M., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K.W., Vogelstein, B., and Clevers, H. (1997). Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinomas. Science 275, 1784-1787.
30. Littlewood, T.D., Hancock, D.C., Danielian, P.S., Parker, M.G., and Evan, G.I. (1995). A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686-1690.
31. Liu, W., Dong, X., Mai, M., Seelan, R.S., Taniguchi, K., Krishnadath, K.K., Hailing, K.C., Cunningham, J.M., Boardman, L.A., Qian, C., et al. (2000). Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signaling. Nat. Genet. 26, 146-147.
32. Liu, Y., Ray, S.K., Yang, X.Q., Luntz-Leybman, V., and Chiu, I.M. (1998). A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box. J. Biol. Chem. 273, 19269-19276.
33. Look, A.T. (1997). Oncogenic transcription factors in the human acute leukemias. Science 278, 1059-1064.
34. Massari, M.E., and Murre, C. (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429-440.
35. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. (1996). XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399.
36. Morin, P.J., Vogelstein, B., and Kinzler, K.W. (1995). Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA 93, 7950-7954.
37. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K.W. (1997). Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790.
38. Murre, C., Bain, G., van Dijk, M.A., Engel, I., Furnari, B.A., Massari, M.E., Matthews, J.R., Quong, M.W., Rivera, R.R., and Stuiver, M.H. (1994). Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta 1218, 129-135.
39. Norton, J.D. (2000). ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897-3905.
40. Norton, J.D., and Atherton, G.T. (1998). Coupling of cell growth control and apoptosis functions of ID proteins. Mol. Cell. Biol. 18, 2371-2381.
41. Parrinello, S., Lin, C.Q., Murata, K., Itahana, Y., Singh, J., Krtolica, A., Campisi, J., and Desprez, P.Y. (2001). Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J. Biol. Chem. 276, 39213-39219.
42. Peifer, M., and Polakis, P. (2000). Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287, 1606-1609.
43. Petropoulos, H., and Skerjanc, I.S. (2000). Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47. J. Biol. Chem. 275, 25095-25101.
44. Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
45. Polakis, P. (2001). More than one way to skin a catenin. Cell 105, 563-566.
46. Rockman, S.P., Currie, S.A., Ciavarella, M., Vincan, E., Dow, C., Thomas, R.J., and Phillips, W.A. (2001). Id2 is a target of the β-catenin/TCF pathway in colon carcinoma. J. Biol. Chem. 276, 45113-45119.
47. Roose, J., Huls, G., van Beest, M., Moerer, P., van der Horn, K., Goldschmeding, R., Logtenberg, T., and Clevers, H. (1999). Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science 285, 1923-1926.
48. Saegusa, M., and Okayasu, I. (2001). Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J. Pathol. 194, 59-67.
49. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24, 245-250.
50. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
51. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, M., D'Amico, M., Pestell, R., and Ben-Ze'ev, A. (1999). The cyclin D1 gene is a target of the β-catenin/ LEF-1 pathway. Proc. Natl. Acad. Sci. USA 11, 5522-5527.
52. Skerjanc, I.S., Truong, J., Filion, P., and McBurney, M.W. (1996). A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity. J. Biol. Chem. 271, 3555-3561.
53. Takayasu, H., Horie, H., Hiyama, E., Matsunaga, T., Hayashi, Y., Watanabe, Y., Suita, S., Kaneko, M., Sasaki, F., Hashizume, K., et al. (2001). Frequent deletions and mutations of the β-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin. Cancer Res. 7, 901-908.
54. Tetsu, O., and McCormick, F. (1999). β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
55. Wan, S., Cato, A.M., and Skaer, H. (2000). Multiple signaling pathways establish cell fate and cell number in Drosophila malpighian tubules. Dev. Biol. 217, 153-165.
56. Wilson, C.L., Heppner, K.J., Labosky, P.A., Hogan, B.L., and Matrisian, L.M. (1997). Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA 94, 1402-1407.
57. Winston, J.T., Strack, P., Beer-Romero, P., Chu, C.Y., Elledge, S.J., and Harper, J.W. (1999). The SCF/β-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IkBα ubiquitination in vitro. Genes Dev. 13, 270-283.
58. Wu, R., Zhai, Y., Fearon, E.R., and Cho, K.R. (2001). Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 61, 8247-8255.
59. Xu, L., Corcoran, R.B., Welsh, J.W., Pennica, D., and Levine, A.J. (2000). WISP-1 is a WNT-1 and beta-catenin-responsive oncogene. Genes Dev. 14, 585-595.
60. Yamada, T., Takaoka, A.S., Naishiro, Y., Hayashi, R., Maruyama, K., Maesawa, C., Ochiai, A., and Hirohashi, S. (2000). Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinomas. Cancer Res. 60, 4761-4766.
61. Yamamoto, H., Kishida, S., Uochi, T., Ikeda, S., Koyama, S., Asashima, M., and Kikuchi, A. (1998). Mol. Cell. Biol. 18, 2867-2875.
62. Yan, D., Wiesmann, M., Rohan, M., Chan, V., Jefferson, A.B., Guo, L., Sakamoto, D., Caothien, R.H., Fuller, J.H., Reinhard, C., et al. (2001). Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors. Proc. Natl. Acad. Sci. USA 98, 14973-14978.
63. Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasieck, T.J., Perry, W.L., III, Lee, J.J., Tilghman, S.M., Gumbiner, B.M., and Costantini, F. (1997). The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90, 181-192.
64. Zhang, T., Otevrel, T., Gao, Z., Ehrlich, S.M., Fields, J.Z., and Boman, B.M. (2001). Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61, 8664-8667.